Correlation Between Pfizer and Tecsys
Can any of the company-specific risk be diversified away by investing in both Pfizer and Tecsys at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Tecsys into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Tecsys Inc, you can compare the effects of market volatilities on Pfizer and Tecsys and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Tecsys. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Tecsys.
Diversification Opportunities for Pfizer and Tecsys
Pay attention - limited upside
The 3 months correlation between Pfizer and Tecsys is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Tecsys Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tecsys Inc and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Tecsys. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tecsys Inc has no effect on the direction of Pfizer i.e., Pfizer and Tecsys go up and down completely randomly.
Pair Corralation between Pfizer and Tecsys
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Tecsys. In addition to that, Pfizer is 1.0 times more volatile than Tecsys Inc. It trades about -0.02 of its total potential returns per unit of risk. Tecsys Inc is currently generating about 0.19 per unit of volatility. If you would invest 2,405 in Tecsys Inc on September 22, 2024 and sell it today you would earn a total of 923.00 from holding Tecsys Inc or generate 38.38% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 98.43% |
Values | Daily Returns |
Pfizer Inc vs. Tecsys Inc
Performance |
Timeline |
Pfizer Inc |
Tecsys Inc |
Pfizer and Tecsys Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pfizer and Tecsys
The main advantage of trading using opposite Pfizer and Tecsys positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Tecsys can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tecsys will offset losses from the drop in Tecsys' long position.Pfizer vs. AbbVie Inc | Pfizer vs. Merck Company | Pfizer vs. Eli Lilly and | Pfizer vs. Bristol Myers Squibb |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |